Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
Phone717-761-2633
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$21.53 billion
Profitability
Miscellaneous
Employees59,000
OptionableOptionable
Rite Aid (NYSE:RAD) Frequently Asked Questions
What is Rite Aid's stock symbol?
Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
How were Rite Aid's earnings last quarter?
Rite Aid Co. (NYSE:RAD) announced its earnings results on Wednesday, December, 19th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.02. The business earned $5.45 billion during the quarter, compared to the consensus estimate of $5.45 billion. Rite Aid had a net margin of 2.85% and a negative return on equity of 0.94%. The business's revenue was up 1.8% compared to the same quarter last year. View Rite Aid's Earnings History.
When is Rite Aid's next earnings date?
What guidance has Rite Aid issued on next quarter's earnings?
Rite Aid issued an update on its FY19 earnings guidance on Wednesday, December, 19th. The company provided earnings per share (EPS) guidance of ($0.03)-($0.01) for the period, compared to the Thomson Reuters consensus EPS estimate of $0.00. The company issued revenue guidance of $21.8-$21.95 billion, compared to the consensus revenue estimate of $21.80 billion.Rite Aid also updated its FY 2019 guidance to $-0.03--0.01 EPS.
What price target have analysts set for RAD?
5 brokers have issued 1-year price targets for Rite Aid's stock. Their predictions range from $1.00 to $6.00. On average, they expect Rite Aid's stock price to reach $2.20 in the next year. This suggests a possible upside of 127.0% from the stock's current price. View Analyst Price Targets for Rite Aid.
What is the consensus analysts' recommendation for Rite Aid?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Rite Aid.
Has Rite Aid been receiving favorable news coverage?
News headlines about RAD stock have trended positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Rite Aid earned a media sentiment score of 2.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days.
Are investors shorting Rite Aid?
Rite Aid saw a decrease in short interest in December. As of December 31st, there was short interest totalling 107,364,070 shares, a decrease of 5.5% from the December 14th total of 113,620,310 shares. Based on an average daily volume of 24,271,324 shares, the short-interest ratio is presently 4.4 days. Currently, 10.2% of the company's shares are sold short. View Rite Aid's Current Options Chain.
Who are some of Rite Aid's key competitors?
Who are Rite Aid's key executives?
Rite Aid's management team includes the folowing people:
- Mr. John T. Standley, CEO & Director (Age 56)
- Mr. Kermit Ray Crawford, Pres & COO (Age 60)
- Mr. Darren Wayne Karst, Sr. EVP, CFO & Chief Admin. Officer (Age 59)
- Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy (Age 49)
- Mr. Bryan B. Everett, Chief Operating Officer of Rite Aid Stores (Age 46)
Who are Rite Aid's major shareholders?
Which institutional investors are buying Rite Aid stock?
How do I buy shares of Rite Aid?
Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rite Aid's stock price today?
One share of RAD stock can currently be purchased for approximately $0.9691.
How big of a company is Rite Aid?
Rite Aid has a market capitalization of $1.03 billion and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 59,000 workers across the globe.
What is Rite Aid's official website?
How can I contact Rite Aid?
Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17011. The company can be reached via phone at 717-761-2633 or via email at [email protected]
MarketBeat Community Rating for Rite Aid (NYSE RAD)
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
